37 77

Cited 2 times in

췌장암과 담관암에서의 염증과 발암

DC FieldValueLanguage
dc.contributor.author이상훈B-
dc.contributor.author박승우-
dc.date.accessioned2019-07-10T01:00:44Z-
dc.date.available2019-07-10T01:00:44Z-
dc.date.issued2015-
dc.identifier.issn1598-9992-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/169764-
dc.description.abstractChronic inflammation has been known to be a risk for many kinds of cancers, including pancreatic and biliary tract cancer. Recently, inflammatory process has emerged as a key mediator of cancer development and progression. Many efforts with experimental results have been given to identify the underlying mechanisms that contribute to inflammation-induced tumorigenesis. Diverse inflammatory pathways have been investigated and inhibitors for inflammation-related signaling pathways have been developed for cancer treatment. This review will summarize recent outcomes about this distinctive process in pancreatic and biliary tract cancer. Taking this evidence into consideration, modulation of inflammatory process will provide useful options for pancreatic and biliary tract cancer treatment.-
dc.description.statementOfResponsibilityopen-
dc.languageKorean-
dc.publisherKorean Society of Gastroenterology-
dc.relation.isPartOfKorean Journal of Gastroenterology-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHBiliary Tract Neoplasms/etiology*-
dc.subject.MESHBiliary Tract Neoplasms/metabolism-
dc.subject.MESHCell Transformation, Neoplastic-
dc.subject.MESHCyclooxygenase 2/metabolism-
dc.subject.MESHCytokines/metabolism-
dc.subject.MESHErbB Receptors/metabolism-
dc.subject.MESHHumans-
dc.subject.MESHInflammation*-
dc.subject.MESHMatrix Metalloproteinases/metabolism-
dc.subject.MESHNF-kappa B/metabolism-
dc.subject.MESHPancreatic Neoplasms/etiology*-
dc.subject.MESHPancreatic Neoplasms/metabolism-
dc.title췌장암과 담관암에서의 염증과 발암-
dc.title.alternativeInflammation and Cancer Development in Pancreatic and Biliary Tract Cancer-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthor이상훈-
dc.contributor.googleauthor박승우-
dc.identifier.doi10.4166/kjg.2015.66.6.325-
dc.contributor.localIdA05737-
dc.contributor.localIdA01551-
dc.contributor.localIdA01551-
dc.relation.journalcodeJ02014-
dc.identifier.eissn2233-6869-
dc.identifier.pmid26691190-
dc.subject.keywordInflammation-
dc.subject.keywordPancreatic adenocarcinoma-
dc.subject.keywordCholangiocarcinoma-
dc.subject.keywordAnti-inflammatory agents-
dc.contributor.alternativeNameLee, Sang Hoon-
dc.contributor.affiliatedAuthor이상훈B-
dc.contributor.affiliatedAuthor박승우-
dc.contributor.affiliatedAuthor박승우-
dc.citation.volume66-
dc.citation.number6-
dc.citation.startPage325-
dc.citation.endPage339-
dc.identifier.bibliographicCitationKorean Journal of Gastroenterology, Vol.66(6) : 325-339, 2015-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.